Global Western Blotting Market To Generate A Revenue Of $860 Million by 2028

The global western blotting market is projected to grow at a CAGR of 5.2% during the forecast period. The global market generated a revenue of over $600 Million in 2021 and is projected to reach a market value of $860 Million by 2028.

Western blotting is an analytical technique used to detect, analyze, and quantify proteins by identifying molecules of specific proteins in the given complex samples like cell lysates and tissue homogenates. The technique involves the separation of proteins with the aid of gel electrophoresis which is followed by transference of the separated proteins to a nitrocellulose membrane or to PVDF.

Once the transfer process is complete, proteins are separated for visualization purposes and are directly identified with the help of mass spectrometry, N-terminal sequencing, or immunodetection.

Western blots have shown immense application in biochemistry by aiding the determination of the extent of post-translational modification, verification of protein expression during cloning applications, the mapping of antibody epitopes, and analysis of biomarker expression levels. The growing need for analysis of more proteins simultaneously in the given limited samples has ultimately aided the improvement of western blotting techniques by improving their sensitivity and speed

The global western blotting market was impacted moderately by the onset of Covid-19. The lack of knowledge and constant mutation of the virus coupled with uncertain situations arising along with the pandemic resulted in increased demand for western blotting technology for research purposes.

Western blotting is used by the world anti-doping agency to detect cases of misuse of substances to increase blood cell levels, which aids the supply of oxygen to muscles externally causing increased stamina accompanied by enhanced performance. However, since the stamina is artificially improved and not a natural trait of the performer, it is considered illegal in many physical competitions and can lead to barring the performer from the sports activity with even stricter implications thus propelling the global western blotting market growth during the projection period. There is rising awareness and prevalence of uncommon diseases, which has forced key players to invest in cost-effective and quick diagnostic techniques to overcome the problems related to diseases like Lyme disease, HIV, and others, pushing the global market growth. This is coupled with the general growth observed in the healthcare sector with constant technological advancements and the adoption of newer technologies. The growth in funds for research about proteins is expected to create a surge in the demand for white blots in the next few years.

The lack of skilled professions is projected to restrict the global market growth. The rising automation in western blotting may provide growth opportunities in the global market during the forecast period. The life cycle complexity of white blots is anticipated to challenge the global market expansion.

The global western blotting market is segmented based on application, product, end-user, and region.

By application, the global market segments are clinical diagnostics, agriculture, and biomedical, and is anticipated to be dominated by the rising application in the biomedical segment. This is owed to the increased funding received from government agencies especially on proteomics research along with the rising need for white blogs in the pharmaceutical sector during the drug development process.

By product, the global market is segmented into instruments and consumables. The instrument segment is divided into electrophoresis, imager (fluorescent), and blotting systems. The consumables segment is showing health signs of high global market growth because of the rise in diseases that require white blotting technology for detection. The blotting system may also register high revenue because of its properties like high efficiency and sensitivity along with lesser run time.

By end-user, hospital, research institute, and biopharma are the global market segments. Research institutes may lead the global market during the projection period.

The global western blotting market is expected to be dominated by North America as it has already been dominating the global market in the last few years. This is mainly due to the innovative approach followed by key manufacturers along with strategic decisions adopted by private players to reach a greater market segment. One such example is the collaborative programs between the US and China to invest in biomedical research along with increased funds for HIV vaccine development. In Europe, Germany is showing healthy growth signs, because of the growing pharmaceutical industries along with an increase in medical diagnostics. Germany seems to be becoming a favorite of many world market leaders. Asia-Pacific is expected to grow significantly as well because of increased government spending on the development of the biomedical sector. In India, the medical services industry is expected to grow from $9.8 Billion to over $65 Billion by 2025 thus aiding the global market growth as well.

The global western blotting market is dominated by players like EMD Millipore Corporation, Bio-Rad Laboratories, Perkin Elmer Inc., LI-COR Inc., Advansta Inc., GE Healthcare, Thermo Fisher Scientific Inc., and Danaher Corporation.

Recent Developments:

• In July 2020, SARS-CoV-2 was launched by Bio-Techne Corporation. The launched product is a multi-antigen serology module especially designed for the Jess and Simple Western automates system using white blotting technology. The technology aided the accelerated research and vaccine development during Covid-19 by systematically characterizing the response of the human immune system to various SARS-CoV-2 antigens.
• In July 2020, virology researchers were supported extensively by LI-COR Biosciences to understand Covid-19 and other viruses with the help of established products, services, and tools. Some of the technology used was the near-infrared western blots and in-cell western assays to study the virus.

Browse the full “Global Western Blotting Market By Application (Clinical Diagnostics, Agriculture, and Biomedical), By Product (Instrument (Electrophoresis, Imager (Fluorescent), & Blotting System) and Consumables (Antibody)), By End-User (Hospital, Research Institute, and Biopharma), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/western-blotting-market

The global western blotting market is segmented as:

By Application

• Clinical Diagnostics
• Agriculture
• Biomedical

By Product

• Instrument
  • Electrophoresis
  • Imager (Fluorescent)
  • Blotting System
•  Consumables (Antibody)

By End-User

• Hospital
• Research Institute
• Biopharma

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com